CANADIAN NATIONAL STOCK EXCHANGE · QNTM
+4.33% · +$0.1400 · Vol 182.0K
Market closed · last close 4:00 PM ET · price as of 19:32:28 ET
Quantum Biopharma Ltd

Quantum Biopharma Ltd

Pharmaceuticals
$3.37
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
QNTM
Quantum Biopharma Ltd
Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

43/ 100
Veridion Score
SELL BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is QNTM moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading QNTM catalysts
About Quantum Biopharma Ltd
Pharmaceuticals
Listed since
2018
Employees
7
Country
CA

Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$3.29
Day high
$3.70
Day low
$3.22
Previous close
$3.23
52W high
$29.21
-88.46% from high
52W low
$2.10
5% of range
Market cap
$22.1M
EPS
$-8.2725
Beta
-0.74
Shares out
6.4M
Volume
182K
1.92× rel vol
Avg volume
95K
VWAP
$3.51
Price history computed in-house
1W
+16.61%
1M
-1.17%
3M
-30.94%
1Y
-88.46%
YTD
-53.84%
SMA 50 $3.69 · below
SMA 200 $5.64 · below
52W position 5%

QNTM overview

Veridion Score
43
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around QNTM.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading QNTM Form 4 filings
Public disclosures

Congress activity in QNTM

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for QNTM in the cached public ledger.

Federal contracts

QNTM contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for QNTM in this window.
Lobbying spend

QNTM lobbying filings, year to date.

Registered lobbying filings matched to Quantum Biopharma Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for QNTM in this window.
Loading news for QNTM
Analyst ratings
Sovereign unlock shows live analyst consensus for QNTM.
Options
Sovereign unlock shows live options positioning for QNTM.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.